Jan L. Garfinkle

Fondateur chez Arboretum Ventures LLC

Profil

Ms. Jan L.
Garfinkle is a Founder & Managing Partner at Arboretum Ventures LLC and a Director & Managing Partner at Reprieve Cardiovascular, Inc. She is on the Board of Directors at Francis Medical, Inc., Trinity Health System, Bank of Ann Arbor, Koya Medical, Inc., RareCyte, Inc., Arbor Bancorp, Inc. and Reprieve Cardiovascular, Inc. Ms. Garfinkle was previously employed as a Board Observer, Investor by nVision Medical Corp., a Board Member by NeuMoDx Molecular, Inc., a Board Member by Ebb Therapeutics, Inc., a Board Member by NXThera, Inc., a Board Observer by Esperion Therapeutics, Inc., a Vice President by Michigan Venture Capital Association, a President by Strategic Marketing Consultants, Inc., a Principal by Abbott Cardiovascular Systems, Inc., an Advisor by Global Cardiovascular Innovation Center, a Chairman by National Venture Capital Association, a Production Line Manager & Manufacturing Engineer by Procter & Gamble Co., an Advisor by University of Michigan, and a Principal by Vascular Intervention.
She also served on the board at Accord Biosciences, Inc., Cardiac Dimensions, Inc., HandyLab, Inc., Life Magnetics, Inc., Sonitus Medical, Inc. and Strata Oncology, Inc. She received her undergraduate degree from the University of California, Berkeley and an MBA from The Wharton School of the University of Pennsylvania.

Postes actifs de Jan L. Garfinkle

Sociétés	Poste	Début
Arboretum Ventures LLC	Fondateur	01/01/2002
Bank of Ann Arbor	Directeur/Membre du Conseil	01/07/2011
RareCyte, Inc.	Directeur/Membre du Conseil	01/09/2021
Koya Medical, Inc.	Directeur/Membre du Conseil	01/12/2020
Arbor Bancorp, Inc.	Directeur/Membre du Conseil	-
Francis Medical, Inc.	Directeur/Membre du Conseil	01/12/2018
Trinity Health System	Directeur/Membre du Conseil	01/01/2017

Anciens postes connus de Jan L. Garfinkle

Sociétés	Poste	Fin
Ebb Therapeutics, Inc.	Directeur/Membre du Conseil	01/12/2020
NeuMoDx Molecular, Inc.	Directeur/Membre du Conseil	01/09/2020
░░░░░░░░ ░░░░░░░ ░░░░░░░ ░░░░░░░░░░░	░░░░░░░░░░	░░░░░░░░░░
░░░░░░░░ ░░░░	░░░░░░░░░░░░░░░░ ░░ ░░░░░░░	░░░░░░░░░░
░░░░░░░ ░░░░░░░ ░░░░░	░░░░░░░░░░░░░░░░ ░░ ░░░░░░░	░░░░░░░░░░